BioNTech
-
Coronavirus: Pfizer-BioNTech warn against plans to delay second shot of vaccine
Scroll Staff
-
BioNTech says it can adapt its coronavirus vaccine in six weeks to tackle new strain
Scroll Staff
-
Coronavirus: UK medicine regulator issues anaphylaxis warning on Pfizer vaccine
Scroll Staff
-
Coronavirus: Pfizer’s vaccine provides strong protection after first dose, says US drug regulator
Scroll Staff
-
Coronavirus: Pfizer applies for emergency use of its vaccine in US, approval expected mid-December
Scroll Staff
-
Covid-19: Pfizer-BioNTech vaccine delivery could start before Christmas if all goes well, says CEO
Scroll Staff
-
‘One step closer to ending pandemic’: Pfizer says its Covid-19 vaccine 90% effective in latest trial
Scroll Staff